JP2014522414A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014522414A5 JP2014522414A5 JP2014514910A JP2014514910A JP2014522414A5 JP 2014522414 A5 JP2014522414 A5 JP 2014522414A5 JP 2014514910 A JP2014514910 A JP 2014514910A JP 2014514910 A JP2014514910 A JP 2014514910A JP 2014522414 A5 JP2014522414 A5 JP 2014522414A5
- Authority
- JP
- Japan
- Prior art keywords
- hemodialysis
- composition
- dialysis
- serum phosphorus
- period
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161494874P | 2011-06-08 | 2011-06-08 | |
| US61/494,874 | 2011-06-08 | ||
| PCT/US2012/041759 WO2012170955A1 (en) | 2011-06-08 | 2012-06-08 | Therapeutic agents for regulating serum phosphorus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014522414A JP2014522414A (ja) | 2014-09-04 |
| JP2014522414A5 true JP2014522414A5 (enExample) | 2015-07-23 |
| JP5982473B2 JP5982473B2 (ja) | 2016-08-31 |
Family
ID=46321485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014514910A Active JP5982473B2 (ja) | 2011-06-08 | 2012-06-08 | 血清リンを調節するための治療剤 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8969299B2 (enExample) |
| EP (1) | EP2717896B1 (enExample) |
| JP (1) | JP5982473B2 (enExample) |
| KR (1) | KR102057508B1 (enExample) |
| CN (1) | CN103857405B (enExample) |
| AU (1) | AU2012267470C1 (enExample) |
| BR (1) | BR112013031539A2 (enExample) |
| CA (1) | CA2837445C (enExample) |
| CY (1) | CY1118430T1 (enExample) |
| DK (1) | DK2717896T3 (enExample) |
| ES (1) | ES2607986T3 (enExample) |
| HR (1) | HRP20161566T1 (enExample) |
| HU (1) | HUE032087T2 (enExample) |
| LT (1) | LT2717896T (enExample) |
| MX (1) | MX337613B (enExample) |
| PL (1) | PL2717896T3 (enExample) |
| PT (1) | PT2717896T (enExample) |
| RS (1) | RS55503B1 (enExample) |
| RU (1) | RU2612912C2 (enExample) |
| SG (1) | SG195290A1 (enExample) |
| SI (1) | SI2717896T1 (enExample) |
| SM (2) | SMT201700081T1 (enExample) |
| WO (1) | WO2012170955A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4154900B1 (en) | 2009-07-29 | 2024-08-28 | Kai Pharmaceuticals, Inc. | Therapeutic agents for reducing parathyroid hormone levels |
| CN114376970A (zh) | 2013-06-28 | 2022-04-22 | 美国安进公司 | Etelcalcetide (AMG 416)的稳定的液体制剂 |
| RU2686086C1 (ru) * | 2018-05-17 | 2019-04-24 | федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации | Способ коррекции пресаркопении или саркопении у пациента с адекватным потреблением основных нутриентов, получающего лечение программным гемодиализом |
| CN118496313A (zh) * | 2019-12-09 | 2024-08-16 | 北京拓界生物医药科技有限公司 | 钙敏感受体激动剂化合物及其应用 |
| CN115087662B (zh) * | 2020-09-10 | 2023-09-26 | 陕西麦科奥特科技有限公司 | 双特异性融合多肽化合物 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5869473A (en) | 1988-08-02 | 1999-02-09 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
| US5602116A (en) | 1988-08-02 | 1997-02-11 | Bone Care International, Inc. | Method for treating and preventing secondary hyperparathyroidism |
| CA1333616C (en) | 1989-03-09 | 1994-12-20 | Hector F. Deluca | 19-nor-vitamin d compounds |
| US5246925A (en) | 1989-03-09 | 1993-09-21 | Wisconsin Alumni Research Foundation | 19-nor-vitamin D compounds for use in treating hyperparathyroidism |
| WO1992008476A1 (en) | 1990-11-07 | 1992-05-29 | The Scripps Research Institute | Peptides that inhibit platelet binding of adhesion molecules |
| US6011068A (en) | 1991-08-23 | 2000-01-04 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| US6031003A (en) | 1991-08-23 | 2000-02-29 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| WO1995006056A1 (en) | 1993-08-20 | 1995-03-02 | University Of Medicine & Dentistry Of New Jersey | Bridged polycationic polymer-oligonucleotide conjugates and methods for preparing same |
| CA2145214A1 (en) | 1995-02-28 | 1996-08-29 | Rick E. Preddie | Agents for pre-symptomatic diagnosis, prevention and cure huntington's disease (hd) in humans |
| US5688489A (en) | 1995-09-15 | 1997-11-18 | Resolution Pharmaceuticals, Inc. | Non-receptor mediated imaging agents |
| US5895368A (en) * | 1996-09-23 | 1999-04-20 | Medisystems Technology Corporation | Blood set priming method and apparatus |
| WO1998017299A1 (en) | 1996-10-18 | 1998-04-30 | The Board Of Trustees Of The Leland Stanford Junior University | Isozyme-specific activators of protein kinase c, methods and compositions |
| US6258774B1 (en) | 1998-03-19 | 2001-07-10 | University Of Medicine And Dentistry Of New Jersey | Carrier for in vivo delivery of a therapeutic agent |
| JP2000336099A (ja) | 1999-05-27 | 2000-12-05 | Sekisui Chem Co Ltd | ペプチド及びｃ型肝炎抗体検出用試薬 |
| US6051567A (en) | 1999-08-02 | 2000-04-18 | Abbott Laboratories | Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol |
| US6274169B1 (en) | 1999-08-02 | 2001-08-14 | Abbott Laboratories | Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol |
| IL153378A0 (en) | 2000-07-18 | 2003-07-06 | Bone Care Internat Inc | STABILIZED 1alpha-HYDROXY VITAMIN D |
| US20080249016A1 (en) | 2000-09-18 | 2008-10-09 | Sanos Bioscience A/S | Use of GLP-2 in a combination treatment for bone-related disorders |
| US20020168354A1 (en) | 2000-11-10 | 2002-11-14 | Daria Mochly-Rosen | psiepsilonRack peptide composition and method for protection against tissue damage due to ischemia |
| WO2002057413A2 (en) | 2001-01-18 | 2002-07-25 | The Board Of Trustees Of The Leland Stanford Junior University | Peptides for activation and inhibition of delta pkc |
| AU2002240312A1 (en) | 2001-02-08 | 2002-08-19 | Pankaj Paranjp | Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents using polymer conjugates |
| US20030036627A1 (en) | 2001-02-16 | 2003-02-20 | Montelaro Ronald C. | Virus derived antimicrobial peptides |
| BRPI0207502B1 (pt) | 2001-02-23 | 2018-10-09 | Polyphor Ltd | compostos, enanciômeros, composição farmacêutica, uso de compostos, e, processo para a fabricação de compostos |
| JP2005287302A (ja) | 2002-04-03 | 2005-10-20 | Haruhiko Fujiwara | ポリペプチドの架橋方法 |
| WO2004039940A2 (en) | 2002-05-14 | 2004-05-13 | Bristol-Myers Squibb Company | Polynucleotide encoding novel human g-protein coupled receptors, and splice variants thereof |
| WO2004093821A2 (en) | 2003-04-22 | 2004-11-04 | Hawaii Biotech, Inc. | Treatment of anthrax infection using inhibitors of lethal factor protease activity |
| EP1680446B1 (en) | 2003-11-05 | 2007-10-31 | Pevion Biotech Ltd. | Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens |
| EP1699813A2 (en) | 2003-12-11 | 2006-09-13 | The Board Of Trustees Of The Leland Stanford Junior University | Isozyme-specific antagonists of protein kinase c |
| WO2005072340A2 (en) | 2004-01-27 | 2005-08-11 | Compugen Ltd. | Novel polynucleotides encoding polypeptides and methods using same |
| US7265092B2 (en) | 2004-09-30 | 2007-09-04 | Kai Pharmaceuticals, Inc. | Pharmaceutical formulation |
| ITME20040015A1 (it) * | 2004-12-07 | 2005-03-07 | Vincenzo Savica | Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. |
| AU2006285127A1 (en) | 2005-08-30 | 2007-03-08 | Acologix, Inc. | Regulation of mineral and skeletal metabolism |
| WO2007038172A2 (en) | 2005-09-23 | 2007-04-05 | Nitto Denko Corporation | Guanidinium carriers |
| US8987200B2 (en) | 2006-11-16 | 2015-03-24 | Kai Pharmaceuticals, Inc. | Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders |
| AU2008206077A1 (en) | 2007-01-19 | 2008-07-24 | Kai Pharmaceuticals, Inc. | Modifications of peptide compositions to increase stability and delivery efficiency |
| NZ584048A (en) | 2007-10-02 | 2012-08-31 | Marina Biotech Inc | Lipopeptides for delivery of nucleic acids |
| EP2229473A4 (en) | 2007-12-07 | 2011-02-02 | Steven A Goldstein | IDENTIFICATION OF TOXIN LIGANDS |
| EP4154900B1 (en) | 2009-07-29 | 2024-08-28 | Kai Pharmaceuticals, Inc. | Therapeutic agents for reducing parathyroid hormone levels |
-
2012
- 2012-06-08 LT LTEP12728907.2T patent/LT2717896T/lt unknown
- 2012-06-08 AU AU2012267470A patent/AU2012267470C1/en active Active
- 2012-06-08 HR HRP20161566TT patent/HRP20161566T1/hr unknown
- 2012-06-08 SM SM20170081T patent/SMT201700081T1/it unknown
- 2012-06-08 SI SI201230784A patent/SI2717896T1/sl unknown
- 2012-06-08 RU RU2013157928A patent/RU2612912C2/ru active IP Right Revival
- 2012-06-08 PT PT127289072T patent/PT2717896T/pt unknown
- 2012-06-08 JP JP2014514910A patent/JP5982473B2/ja active Active
- 2012-06-08 US US13/492,778 patent/US8969299B2/en active Active
- 2012-06-08 KR KR1020137034736A patent/KR102057508B1/ko active Active
- 2012-06-08 DK DK12728907.2T patent/DK2717896T3/en active
- 2012-06-08 MX MX2013014249A patent/MX337613B/es active IP Right Grant
- 2012-06-08 RS RS20161021A patent/RS55503B1/sr unknown
- 2012-06-08 ES ES12728907.2T patent/ES2607986T3/es active Active
- 2012-06-08 HU HUE12728907A patent/HUE032087T2/en unknown
- 2012-06-08 CA CA2837445A patent/CA2837445C/en active Active
- 2012-06-08 CN CN201280038112.5A patent/CN103857405B/zh active Active
- 2012-06-08 PL PL12728907T patent/PL2717896T3/pl unknown
- 2012-06-08 EP EP12728907.2A patent/EP2717896B1/en active Active
- 2012-06-08 BR BR112013031539A patent/BR112013031539A2/pt not_active Application Discontinuation
- 2012-06-08 SG SG2013089594A patent/SG195290A1/en unknown
- 2012-06-08 WO PCT/US2012/041759 patent/WO2012170955A1/en not_active Ceased
-
2016
- 2016-11-24 CY CY20161101220T patent/CY1118430T1/el unknown
-
2017
- 2017-02-06 SM SM201700081T patent/SMT201700081B/it unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| JP2015502346A5 (enExample) | ||
| JP6381761B2 (ja) | 低減された投与容量を必要とする患者におけるベンダムスチン応答性症状の治療方法 | |
| JP2016528247A5 (enExample) | ||
| JP2016518387A5 (enExample) | ||
| JP2014502641A5 (enExample) | ||
| JP2015520188A5 (enExample) | ||
| WO2007081975A2 (en) | Method of treating multiple sclerosis | |
| JP2016516016A5 (enExample) | ||
| CN104203232A (zh) | 用于抗肿瘤试剂施用的方法 | |
| JP2024516363A (ja) | リボシクリブ及びアムセネストラントを含む組み合わせ | |
| FI3518932T3 (fi) | Eturauhassyövän hoito | |
| JP2020502261A5 (enExample) | ||
| JP2014513705A (ja) | 進行性固形腫瘍の治療方法 | |
| JP2018531605A5 (enExample) | ||
| JP2015522077A5 (enExample) | ||
| Kumar et al. | Weekly MLN9708, an investigational oral proteasome inhibitor, in relapsed/refractory multiple myeloma: results from a phase I study after full enrollment | |
| JP6743001B2 (ja) | シス−クロミフェンを用いたアンドロゲン除去療法によって生じるホットフラッシュ及び骨量減少の治療 | |
| JP2016515137A5 (enExample) | ||
| JP2014530204A5 (enExample) | ||
| RU2013157928A (ru) | Терапевтические средства для регуляции уровня фосфора в сыворотке | |
| JP2022514561A5 (enExample) | ||
| JP2018529747A5 (enExample) | ||
| FI3359572T3 (fi) | Menetelmä multippeliskleroosin hoitamiseksi | |
| JP2015512923A5 (enExample) |